Alkem Laboratories informs about press release

28 Feb 2024 Evaluate
In furtherance to the intimation captioned ‘US FDA Inspection at Company’s API manufacturing facility located at Mandva’ dated 01st December, 2023, Alkem Laboratories has informed that US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility. The Inspection has been classified as Voluntary Action Indicated (VAI) and was closed accordingly.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5835.20 6.50 (0.11%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×